DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 — Canadian drug shortage status
Manufacturer: GLENMARK PHARMACEUTICALS CANADA INC.
0 active reports
Shortage reports for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 filed with Health Canada's drug shortage register, as tracked by Nexara. Each row is one reported presentation or strength.
| Status | Strength / detail | Estimated resolution | Tier | Last seen | Source |
|---|---|---|---|---|---|
| resolved | 0.03MG 3MG | 2026-04-13 | healthproductshortages.ca |
Sourcing during a shortage
When a Canadian product is in shortage, Health Canada may permit exceptional importation of a foreign-authorized equivalent, and practitioners may apply through the Special Access Programme. Read how named-patient and foreign-pack supply works in Canada.
Request a quote for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21